Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.
European Journal of Nuclear Medicine and Molecular Imaging.
Times cited: 69
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors.
Clinical Cancer Research.
Times cited: 152